{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 209,
  "pageCount": 239,
  "prevPage": 208,
  "nextPage": 210,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/209",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-209",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.88,
        "x": 0.06,
        "y": 0.43
      },
      "kind": "callout",
      "text": "“Medical device companies are particularly at risk with respect to FCPA violations. [...] More directly, practices that are common in the medical device industry, such as product discounts tied to purchase volume and incentive programs to encourage increased purchasing, may violate both the letter and the spirit of the FCPA.”",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fd63406-1109-4643-8655-6ca56724187a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.73
      },
      "kind": "callout",
      "text": "“In recent years, the medical device industry has been in the spotlight and subject to increased scrutiny by government regulators. The U.S. Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have pursued several companies in the medical device industry for a number of Foreign Corrupt Practices Act (FCPA) violations, including kickbacks with foreign health departments, payments to consultants in hospitals, unjustified fees and using excessive means to influence healthcare professionals.”",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e76cbd3a-0112-4d23-afc2-2382ad7f3e82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b348-a0f092cea778",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.06,
        "y": 0.56
      },
      "kind": "paragraph",
      "text": "Emerging Risk Trends in the Medical Device Industry: Whistleblowing, Anti-Bribery, Corruption Law and Enforcement",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19d90d66-3857-4a16-8f82-e381659d0311",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "A review of enforcement actions brought against medical device companies under the Foreign Corrupt Practices Act leads us to believe that Nevro and its executives may be one internal whistleblower and/or inquisitive DOJ attorney away from a major FCPA problem.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7824976-f943-4b69-bbc5-32028494d85d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Medical device companies are particularly at risk with respect to FCPA violations. [...] More directly, practices that are common in the medical device industry, such as product discounts tied to purchase volume and incentive programs to encourage increased purchasing, may violate both the letter and the spirit of the FCPA.” — MD+DI Online",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b348-a437d8d42f4f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.88,
        "x": 0.06,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Source: https://www.mddionline.com/news/foreign-corrupt-practices-act-high-risks-medical-device-industry; https://www.kroll.com/en/insights/publications/compliance-risk/emerging-risk-trends-in-the-medical-device-industry",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "119e8269-c10c-4904-baaa-a02c19ead1ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.88,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "17. We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c15abe9-9ade-4234-b4ef-aa42616d51d8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.5,
        "x": 0.06,
        "y": 0.34
      },
      "kind": "title",
      "text": "Foreign Corrupt Practices Act: High Risks for the Medical Device Industry",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44fb0198-de5f-4f11-92ad-d1d8720683ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b0b24b7-5532-4a67-afaf-3aad62fc81d6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "08183c94-15ee-4539-afb3-d72060723fdd",
      "evidence": "The slide explicitly links the company's business model to potential legal violations (FCPA) and regulatory scrutiny.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}